Hydration Pharmaceuticals : Application for quotation of securities - HPC
March 16, 2022 at 06:51 pm
Share
Application for quotation of +securities
Announcement Summary
For personal use only
Entity name
THE HYDRATION PHARMACEUTICALS COMPANY LIMITED
Announcement Type
New announcement
Date of this announcement
Thursday March 17, 2022
The +securities to be quoted are:
+Restricted securities where the escrow period has expired or is about to expire
Total number of +securities to be quoted
ASX +security
Number of +securities to
code
Security description
be quoted
Issue date
HPC
ORDINARY FULLY PAID
8,962,224
18/03/2022
Refer to next page for full details of the announcement
Application for quotation of +securities
1 / 8
Application for quotation of +securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
THE HYDRATION PHARMACEUTICALS COMPANY LIMITED
We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2
Registered number type
Registration number
ACN
620385677
1.3
ASX issuer code
HPC
The announcement is New announcement
Date of this announcement
17/3/2022
Application for quotation of +securities
2 / 8
Application for quotation of +securities
Part 2 - Type of Issue
2.1 The +securities to be quoted are:
+Restricted securities where the escrow period has expired or is about to expire
For personal use only
2.2 The +securities to be quoted are:
Additional +securities in a class that is already quoted on ASX ("existing class")
Application for quotation of +securities
3 / 8
Application for quotation of +securities
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B
For personal use only
Additional +securities to be quoted in an existing class as a result of escrow expiring on an existing class
FROM (Existing Class)
ASX +security code and description
HPCAA : ORDINARY FULLY PAID RESTRICTED
TO (Existing Class)
ASX +security code and description
HPC : ORDINARY FULLY PAID
Please state the number of +restricted securities where the escrow period
And the date the escrow restrictions
has expired or is about to expire
have ceased or will cease
8,962,224
18/3/2022
Issue date
18/3/2022
Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?
Yes
Application for quotation of +securities
4 / 8
Application for quotation of +securities
Issue details
For personal use only
Number of +securities to be quoted
8,962,224
Are the +securities being issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
The securities are being released from escrow restrictions and therefore no consideration is required to be provided.
Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted
2,150,933.760000
Any other information the entity wishes to provide about the +securities to be quoted
Application for quotation of +securities
5 / 8
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Hydration Pharmaceuticals Co. Ltd. published this content on 16 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 March 2022 22:50:01 UTC.
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, China, and the United Kingdom. Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.